These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23740114)

  • 21. Fullerenol C
    Kazmierska-Grebowska P; Kobrzycka A; Bocian R; Kowalczyk T; Krokosz A; Grebowski J
    Exp Mol Pathol; 2018 Aug; 105(1):98-109. PubMed ID: 29909157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas.
    Injac R; Perse M; Obermajer N; Djordjevic-Milic V; Prijatelj M; Djordjevic A; Cerar A; Strukelj B
    Biomaterials; 2008; 29(24-25):3451-60. PubMed ID: 18501960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Fullerenol C
    Grebowski J; Kazmierska-Grebowska P; Cichon N; Piotrowski P; Litwinienko G
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008545
    [No Abstract]   [Full Text] [Related]  

  • 24. Fullerenol C
    Grebowski J; Kazmierska-Grebowska P; Cichon N; Konarska A; Wolszczak M; Litwinienko G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo biology and toxicology of fullerenes and their derivatives.
    Nielsen GD; Roursgaard M; Jensen KA; Poulsen SS; Larsen ST
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):197-208. PubMed ID: 18684229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fullerenolates: metallated polyhydroxylated fullerenes with potent anti-amyloid activity.
    Bobylev AG; Kornev AB; Bobyleva LG; Shpagina MD; Fadeeva IS; Fadeev RS; Deryabin DG; Balzarini J; Troshin PA; Podlubnaya ZA
    Org Biomol Chem; 2011 Aug; 9(16):5714-9. PubMed ID: 21713297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and In Vivo Evaluation of Hydrophilic C60(OH)10/2-Hydroxypropyl-β-cyclodextrin Nanoparticles as an Antioxidant.
    Iohara D; Umezaki Y; Anraku M; Uekama K; Hirayama F
    J Pharm Sci; 2016 Sep; 105(9):2959-2965. PubMed ID: 27317367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of dextran stabilized fullerene C
    Biby TE; Prajitha N; Ashtami J; Sakthikumar D; Maekawa T; Mohanan PV
    Brain Res Bull; 2020 Feb; 155():191-201. PubMed ID: 31786269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
    Isakovic A; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Mirkovic M; Dramicanin M; Harhaji L; Raicevic N; Nikolic Z; Trajkovic V
    Toxicol Sci; 2006 May; 91(1):173-83. PubMed ID: 16476688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fullerenol-cytotoxic conjugates for cancer chemotherapy.
    Chaudhuri P; Paraskar A; Soni S; Mashelkar RA; Sengupta S
    ACS Nano; 2009 Sep; 3(9):2505-14. PubMed ID: 19681636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Characterization of Hydroxyapatite/Fullerenol Nanocomposites.
    Djordjevic A; Ignjatovic N; Seke M; Jovic D; Uskokovic D; Rakocevic Z
    J Nanosci Nanotechnol; 2015 Feb; 15(2):1538-42. PubMed ID: 26353688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano-C60 cytotoxicity is due to lipid peroxidation.
    Sayes CM; Gobin AM; Ausman KD; Mendez J; West JL; Colvin VL
    Biomaterials; 2005 Dec; 26(36):7587-95. PubMed ID: 16005959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C(60)(OH)(24).
    Milic VD; Stankov K; Injac R; Djordjevic A; Srdjenovic B; Govedarica B; Radic N; Simic VD; Strukelj B
    Toxicol Mech Methods; 2009 Jan; 19(1):24-8. PubMed ID: 19778229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioluminescent Enzymatic Assay as a Tool for Studying Antioxidant Activity and Toxicity of Bioactive Compounds.
    Kudryasheva NS; Kovel ES; Sachkova AS; Vorobeva AA; Isakova VG; Churilov GN
    Photochem Photobiol; 2017 Mar; 93(2):536-540. PubMed ID: 27645453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The polyhydroxylated fullerene derivative C60(OH)24 protects mice from ionizing-radiation-induced immune and mitochondrial dysfunction.
    Cai X; Hao J; Zhang X; Yu B; Ren J; Luo C; Li Q; Huang Q; Shi X; Li W; Liu J
    Toxicol Appl Pharmacol; 2010 Feb; 243(1):27-34. PubMed ID: 19914272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fullerenol nanoparticles on acetamiprid induced cytoxicity and genotoxicity in cultured human lung fibroblasts.
    Çavaş T; Çinkılıç N; Vatan Ö; Yılmaz D
    Pestic Biochem Physiol; 2014 Sep; 114():1-7. PubMed ID: 25175643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneities in fullerene nanoparticle aggregates affecting reactivity, bioactivity, and transport.
    Chae SR; Badireddy AR; Farner Budarz J; Lin S; Xiao Y; Therezien M; Wiesner MR
    ACS Nano; 2010 Sep; 4(9):5011-8. PubMed ID: 20707347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidative fullerol promotes osteogenesis of human adipose-derived stem cells.
    Yang X; Li CJ; Wan Y; Smith P; Shang G; Cui Q
    Int J Nanomedicine; 2014; 9():4023-31. PubMed ID: 25187705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C70-carboxyfullerenes as efficient antioxidants to protect cells against oxidative-induced stress.
    Liu Q; Zhang X; Zhang X; Zhang G; Zheng J; Guan M; Fang X; Wang C; Shu C
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):11101-7. PubMed ID: 24150592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors.
    Turabekova M; Rasulev B; Theodore M; Jackman J; Leszczynska D; Leszczynski J
    Nanoscale; 2014 Apr; 6(7):3488-95. PubMed ID: 24548972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.